drugset / Trial / NCT01501695
Phase III Study of 5LGr to Treat Tic Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the effective and safety of 5LGr in pediatric patients with tic disorders.
Timeline
- Start
- 2008-01
- Primary completion
- 2010-11
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 5LGr | Traditional medicine (herbal / TCM) | 5 g | — |
| Subject | 5LGr | Traditional medicine (herbal / TCM) | 7.5 g | — |
| Comparator | Tiapride | Small molecule | 100 mg | — |
| Comparator | Tiapride | Small molecule | 200 mg | — |